Myocardial Injury Biomarkers in Newborns with Congenital Heart Disease

Myocardial Injury Biomarkers in Newborns with Congenital Heart Disease

Troponin I, myoglobin, and creatine kinase-MB mass (CK-MB) are biomarkers of cardiomyocyte injury widely used in the management of adult patients. The role of these biomarkers in newborns is still not established. The purpose of this study was to evaluate the value of cardiac injury biomarkers in ne...

Full description

Bibliographic Details
Main Authors: Ana Luisa Neves, Maria Cabral, Adelino Leite-Moreira, José Monterroso, Carla Ramalho, Hercília Guimarães, Henrique Barros, João T. Guimarães, Tiago Henriques-Coelho, José C. Areias
Format: Article
Language:English
Published: Elsevier 2016-12-01
Series:Pediatrics and Neonatology
Subjects:
cardiac biomarkers
congenital heart disease
echocardiography
outcome
Online Access:http://www.sciencedirect.com/science/article/pii/S1875957216300195

Internet

http://www.sciencedirect.com/science/article/pii/S1875957216300195

Similar Items